Norton Johna 4
4 · ELI LILLY & Co · Filed Feb 3, 2023
Insider Transaction Report
Form 4
Norton Johna
Senior VP, Global Quality
Transactions
- Tax Payment
Common Stock
2023-02-01$344.15/sh−941$323,845→ 31,401 total - Exercise/Conversion
Common Stock
2023-02-01+2,102→ 32,342 total - Exercise/Conversion
Restricted Stock Unit
2023-02-01−2,102→ 0 totalFrom: 2023-02-01Exp: 2023-02-01→ Common Stock (2,102 underlying)
Holdings
- 128(indirect: by partner)
Common Stock
- 399(indirect: By 401(k))
Common Stock
- 1,756(indirect: By 401(k))
Common Stock
Footnotes (4)
- [F1]Reporting person disclaims beneficial ownership of these shares.
- [F2]Amount reflects reduction in shares beneficially held in partner's 401(k) plan account to correct a prior administrative error of a third-party 401(k) administrator.
- [F3]Amount reflects reduction in shares beneficially held in reporting person's 401(k) plan account to correct a prior administrative error of a third-party 401(k) administrator.
- [F4]Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.